Alaunos Therapeutics | ZIOP - Passifs Courants





Passifs Courants Changement Date
Alaunos Therapeutics USD 595K 218K 2026-03
Amgen USD 25.5B 547M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Baxter International USD 3.59B 102M 2026-06
Biogen USD 3.92B 918.2M 2026-06
Bioline Rx USD 13.62M 1.5M 2026-03
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Celltrion KRW 292.71B 9.09B 2026-03
Corcept Therapeutics USD 153.8M 4.62M 2026-06
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Curis USD 14.97M 898K 2026-03
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 34.39M 3.89M 2026-06
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Gilead Sciences USD 11.02B 1.54B 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
Incyte USD 1.31B 177.55M 2026-06
Intrexon USD 23.02M 38K 2024-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
J&J USD 54.9B 2.82B 2026-06
Kangmei Pharma CNY 5.38B 433.79M 2026-03
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Merck USD 27.73B 786M 2026-06
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Novartis USD 31.75B 374M 2026-06
Organigram Holdings CAD 88.74M 5.31M 2026-03
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pfizer USD 32.65B 1.7B 2026-06
Pharma Mar EUR 98.42M 9.2M 2026-06
PTC Therapeutics USD 771.07M 152.54M 2026-06
Qiagen NV USD 581.45M 102.34M 2026-06
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sartorius EUR 1.44B 668.7M 2026-06
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
TG Therapeutics USD 268.49M 81.38M 2026-06
Tilray USD 259.32M 8.32M 2025-09
Verastem USD 66.84M 5.42M 2026-03
Zealand Pharma A/S 404M 260.96M 2026-03
Zz Pientze Pharmaceu CNY 2.28B 134.52M 2026-03